Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$586K Buy
4,960
+603
+14% +$74.6K 0.03% 379
2025
Q4
$540K Buy
4,357
+265
+6% +$34.6K 0.03% 384
2025
Q3
$594K Sell
4,092
-523
-11% -$79.1K 0.03% 380
2025
Q2
$675K Sell
4,615
-18
-0.4% -$2.85K 0.04% 331
2025
Q1
$763K Buy
4,633
+142
+3% +$23.6K 0.07% 246
2024
Q4
$732K Sell
4,491
-417
-8% -$74.6K 0.05% 312
2024
Q3
$959K Buy
4,908
+193
+4% +$35.6K 0.06% 277
2024
Q2
$817K Sell
4,715
-247
-5% -$41.1K 0.24% 60
2024
Q1
$836K Buy
4,962
+684
+16% +$128K 0.07% 251
2023
Q4
$844K Buy
4,278
+246
+6% +$43.5K 0.07% 253
2023
Q3
$702K Buy
4,032
+664
+20% +$121K 0.07% 245
2023
Q2
$580K Buy
3,368
+249
+8% +$43K 0.05% 307
2023
Q1
$519K Buy
+3,119
New +$511K 0.05% 269

Other funds holding ZTS

NWAM LLC's ZTS Position: Q1 2026 in Review

NWAM LLC increased its Zoetis (ZTS) stake by 14% in Q1 2026, buying an estimated $74.6K and bringing the position to 4,960 shares worth $586K. The position accounts for 0.03% of the portfolio, ranked #379.

NWAM LLC first reported a position in ZTS in Q1 2023 and has held it in 13 quarters since. The position peaked at $959K in Q3 2024. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • NWAM LLC held 4,960 shares of Zoetis worth $586K as of Q1 2026.
  • NWAM LLC bought 603 Zoetis shares in Q1 2026, an estimated $74.6K.
  • Zoetis made up 0.03% of NWAM LLC's portfolio in Q1 2026, its #379 holding.
  • NWAM LLC first reported a position in Zoetis in Q1 2023 and has held it in 13 quarters since.
  • NWAM LLC's Zoetis position peaked at $959K in Q3 2024.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.